TreeWAS – Variant ID: rs1816854

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C67.4 Posterior wall of bladder	0.020	0.980	0.000
C67 Malignant neoplasm of bladder	0.020	0.980	0.000
K83.0 Cholangitis	0.000	0.981	0.019
K83 Other diseases of biliary tract	0.000	0.981	0.019
C67.1 Dome of bladder	0.018	0.982	0.000
K70.9 Alcoholic liver disease, unspecified	0.018	0.982	0.000
K70.0 Alcoholic fatty liver	0.018	0.982	0.000
K70 Alcoholic liver disease	0.018	0.982	0.000
K83.9 Disease of biliary tract, unspecified	0.000	0.982	0.018
K83.8 Other specified diseases of biliary tract	0.000	0.983	0.017
C67.0 Trigone of bladder	0.017	0.983	0.000
K70.3 Alcoholic cirrhosis of liver	0.017	0.983	0.000
C67.2 Lateral wall of bladder	0.016	0.984	0.000
C67.3 Anterior wall of bladder	0.016	0.984	0.000
C67.5 Bladder neck	0.016	0.984	0.000
K83.1 Obstruction of bile duct	0.000	0.984	0.016
C67.6 Ureteric orifice	0.016	0.984	0.000
K70.4 Alcoholic hepatic failure	0.014	0.985	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.014	0.986	0.000
C67.7 Urachus	0.014	0.986	0.000
K83.5 Biliary cyst	0.000	0.986	0.013
K83.4 Spasm of sphincter of Oddi	0.000	0.986	0.013
K83.3 Fistula of bile duct	0.000	0.986	0.013
K83.2 Perforation of bile duct	0.000	0.986	0.013
C67.8 Overlapping lesion of bladder	0.012	0.988	0.000
K70.1 Alcoholic hepatitis	0.010	0.990	0.000
C64-C68 Malignant neoplasms of urinary tract	0.010	0.990	0.000
C66 Malignant neoplasm of ureter	0.010	0.990	0.000
C67.9 Bladder, unspecified	0.009	0.991	0.000
N21.0 Calculus in bladder	0.008	0.992	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.008	0.992	0.000
A41.0 Septicaemia due to Staphylococcus aureus	0.000	0.992	0.008
A41 Other septicaemia	0.000	0.992	0.008
A41.5 Septicaemia due to other Gram-negative organisms	0.000	0.992	0.007
A41.8 Other specified septicaemia	0.000	0.993	0.007
C68.9 Urinary organ, unspecified	0.007	0.993	0.000
C65 Malignant neoplasm of renal pelvis	0.007	0.993	0.000
Y45.0 Opioids and related analgesics	0.007	0.993	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.993	0.007
A41.2 Septicaemia due to unspecified staphylococcus	0.000	0.993	0.007
A41.1 Septicaemia due to other specified staphylococcus	0.000	0.993	0.007
C68.8 Overlapping lesion of urinary organs	0.006	0.994	0.000
C68.1 Paraurethral glands	0.006	0.994	0.000
C68.0 Urethra	0.006	0.994	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.006	0.994	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.000	0.994	0.006
A41.4 Septicaemia due to anaerobes	0.000	0.994	0.006
A41.3 Septicaemia due to Haemophilus influenzae	0.000	0.994	0.006
W07.9 Unspecified place	0.006	0.994	0.000
N92.1 Excessive and frequent menstruation with irregular cycle	0.006	0.994	0.000
Y45.8 Other analgesics and antipyretics	0.005	0.994	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.005	0.995	0.000
Y45.5 4-Aminophenol derivatives	0.005	0.995	0.000
N21 Calculus of lower urinary tract	0.005	0.995	0.000
A49.8 Other bacterial infections of unspecified site	0.000	0.995	0.005
N21.1 Calculus in urethra	0.005	0.995	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
Y45.2 Propionic acid derivatives	0.005	0.995	0.000
Y45.4 Antirheumatics	0.005	0.995	0.000
A49 Bacterial infection of unspecified site	0.000	0.995	0.005
Y41.0 Sulphonamides	0.005	0.995	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.995	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.005	0.995	0.000
A49.0 Staphylococcal infection, unspecified	0.000	0.995	0.005
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.995	0.000
Y54.5 Other diuretics	0.004	0.996	0.000
Y40 Systemic antibiotics	0.004	0.996	0.000
Y55.4 Expectorants	0.004	0.996	0.000
A30-A49 Other bacterial diseases	0.000	0.996	0.004
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y41.1 Antimycobacterial drugs	0.004	0.996	0.000
W07 Fall involving chair	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
N21.9 Calculus of lower urinary tract, unspecified	0.004	0.996	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
Y49.2 Other and unspecified antidepressants	0.004	0.996	0.000
Y41.5 Antiviral drugs	0.004	0.996	0.000
Y54.4 Loop [high-ceiling] diuretics	0.004	0.996	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
Y58 Bacterial vaccines	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
Y41.4 Anthelminthics	0.004	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.004	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.004	0.996	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
Y54.8 Agents affecting uric acid metabolism	0.004	0.996	0.000
S22.30 Fracture of rib (closed)	0.000	0.996	0.004
A49.1 Streptococcal infection, unspecified	0.000	0.996	0.004
N88.2 Stricture and stenosis of cervix uteri	0.004	0.996	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
N21.8 Other lower urinary tract calculus	0.004	0.996	0.000
Y53.4 Other laxatives	0.004	0.996	0.000
A49.3 Mycoplasma infection, unspecified	0.000	0.996	0.004
Y40.0 Penicillins	0.004	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.996	0.000
Y55.5 Anticommon cold drugs	0.003	0.996	0.000
Y55.3 Antitussives	0.003	0.996	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.996	0.000
Y55.0 Oxytocic drugs	0.003	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.996	0.000
Y40.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.996	0.000
Y54.7 Agents affecting calcification	0.003	0.996	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.996	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.996	0.000
Y54.0 Mineralocorticoids	0.003	0.996	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.004	0.996	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.996	0.000
Y57.6 Other diagnostic agents	0.003	0.996	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.996	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.996	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.996	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.996	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.996	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.996	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.996	0.000
Y46.4 Iminostilbenes	0.003	0.997	0.000
A49.2 Haemophilus influenzae infection, unspecified	0.000	0.997	0.003
Y40.5 Aminoglycosides	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
G99.2 Myelopathy in diseases classified elsewhere	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.003	0.997	0.000
A44 Bartonellosis	0.000	0.997	0.003
A43 Nocardiosis	0.000	0.997	0.003
A42 Actinomycosis	0.000	0.997	0.003
A37 Whooping cough	0.000	0.997	0.003
A36 Diphtheria	0.000	0.997	0.003
A32 Listeriosis	0.000	0.997	0.003
A31 Infection due to other mycobacteria	0.000	0.997	0.003
A30 Leprosy [Hansen's disease]	0.000	0.997	0.003
A38 Scarlet fever	0.000	0.997	0.003
A35 Other tetanus	0.000	0.997	0.003
A34 Obstetrical tetanus	0.000	0.997	0.003
A33 Tetanus neonatorum	0.000	0.997	0.003
D26.1 Corpus uteri	0.000	0.997	0.003
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
W07.0 Home	0.003	0.997	0.000
Y54.3 Benzothiadiazine derivatives	0.003	0.997	0.000
W07.2 School, other institution and public administrative area	0.003	0.997	0.000
W07.8 Other specified place	0.003	0.997	0.000
W07.7 Farm	0.003	0.997	0.000
W07.6 Industrial and construction area	0.003	0.997	0.000
W07.5 Trade and service area	0.003	0.997	0.000
W07.4 Street and highway	0.003	0.997	0.000
W07.3 Sports and athletics area	0.003	0.997	0.000
W07.1 Residential institution	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
A49.9 Bacterial infection, unspecified	0.000	0.997	0.003
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
A39 Meningococcal infection	0.000	0.997	0.003
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.003	0.997	0.000
N50.9 Disorder of male genital organs, unspecified	0.000	0.997	0.003
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.000	0.997	0.003
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
A40 Streptococcal septicaemia	0.000	0.997	0.003
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
X51.8 Other specified place	0.003	0.997	0.000
N50.8 Other specified disorders of male genital organs	0.000	0.997	0.003
W22.3 Sports and athletics area	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
Chapter XX External causes of morbidity and mortality	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
V99 Unspecified transport accident	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
N50 Other disorders of male genital organs	0.000	0.997	0.003
V98-V99 Other and unspecified transport accidents	0.003	0.997	0.000
N50.0 Atrophy of testis	0.000	0.997	0.003
Y45.1 Salicylates	0.003	0.997	0.000
X51 Travel and motion	0.003	0.997	0.000
I31.9 Disease of pericardium, unspecified	0.000	0.997	0.003
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.003	0.997	0.000
X50-X57 Overexertion, travel and privation	0.003	0.997	0.000
S02.10 Fracture of base of skull (closed)	0.003	0.997	0.000
G94.1 Hydrocephalus in neoplastic disease	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
A48 Other bacterial diseases, not elsewhere classified	0.000	0.997	0.003
W00-W19 Falls	0.003	0.997	0.000
N50.1 Vascular disorders of male genital organs	0.000	0.997	0.003
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.997	0.000
Y47.4 Bromine compounds	0.002	0.997	0.000
Y47.3 Paraldehyde	0.002	0.997	0.000
Y47.2 Chloral derivatives	0.002	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.997	0.000
A46 Erysipelas	0.000	0.997	0.003
V20-V29 Motorcycle rider injured in transport accident	0.003	0.997	0.000
W79.2 School, other institution and public administrative area	0.003	0.997	0.000
M24.87 Other specific joint derangements, not elsewhere classified (Ankle and foot)	0.003	0.997	0.000
S42.40 Fracture of lower end of humerus (closed)	0.000	0.997	0.003
V28 Motorcycle rider injured in noncollision transport accident	0.003	0.997	0.000
W75-W84 Other accidental threats to breathing	0.003	0.997	0.000
A30.9 Leprosy, unspecified	0.000	0.997	0.002
A30.8 Other forms of leprosy	0.000	0.997	0.002
A30.5 Lepromatous leprosy	0.000	0.997	0.002
A30.4 Borderline lepromatous leprosy	0.000	0.997	0.002
A30.3 Borderline leprosy	0.000	0.997	0.002
A30.2 Borderline tuberculoid leprosy	0.000	0.997	0.002
A30.1 Tuberculoid leprosy	0.000	0.997	0.002
A30.0 Indeterminate leprosy	0.000	0.997	0.002
A31.9 Mycobacterial infection, unspecified	0.000	0.997	0.002
A31.8 Other mycobacterial infections	0.000	0.997	0.002
A31.1 Cutaneous mycobacterial infection	0.000	0.997	0.002
A31.0 Pulmonary mycobacterial infection	0.000	0.997	0.002
A32.9 Listeriosis, unspecified	0.000	0.997	0.002
A32.8 Other forms of listeriosis	0.000	0.997	0.002
A32.7 Listerial septicaemia	0.000	0.997	0.002
A32.1 Listerial meningitis and meningoencephalitis	0.000	0.997	0.002
A32.0 Cutaneous listeriosis	0.000	0.997	0.002
A36.9 Diphtheria, unspecified	0.000	0.997	0.002
A36.8 Other diphtheria	0.000	0.997	0.002
A36.3 Cutaneous diphtheria	0.000	0.997	0.002
A36.2 Laryngeal diphtheria	0.000	0.997	0.002
A36.1 Nasopharyngeal diphtheria	0.000	0.997	0.002
A36.0 Pharyngeal diphtheria	0.000	0.997	0.002
A37.9 Whooping cough, unspecified	0.000	0.997	0.002
A37.8 Whooping cough due to other Bordetella species	0.000	0.997	0.002
A37.1 Whooping cough due to Bordetella parapertussis	0.000	0.997	0.002
A37.0 Whooping cough due to Bordetella pertussis	0.000	0.997	0.002
A42.9 Actinomycosis, unspecified	0.000	0.997	0.002
A42.8 Other forms of actinomycosis	0.000	0.997	0.002
A42.7 Actinomycotic septicaemia	0.000	0.997	0.002
A42.2 Cervicofacial actinomycosis	0.000	0.997	0.002
A42.1 Abdominal actinomycosis	0.000	0.997	0.002
A42.0 Pulmonary actinomycosis	0.000	0.997	0.002
A43.9 Nocardiosis, unspecified	0.000	0.997	0.002
A43.8 Other forms of nocardiosis	0.000	0.997	0.002
A43.1 Cutaneous nocardiosis	0.000	0.997	0.002
A43.0 Pulmonary nocardiosis	0.000	0.997	0.002
A44.9 Bartonellosis, unspecified	0.000	0.997	0.002
A44.8 Other forms of bartonellosis	0.000	0.997	0.002
A44.1 Cutaneous and mucocutaneous bartonellosis	0.000	0.997	0.002
A44.0 Systemic bartonellosis	0.000	0.997	0.002
X40-X49 Accidental poisoning by and exposure to noxious substances	0.003	0.997	0.000
X00-X09 Exposure to smoke, fire and flames	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.002	0.997	0.000
W22 Striking against or struck by other objects	0.003	0.997	0.000
W79 Inhalation and ingestion of food causing obstruction of respiratory tract	0.002	0.997	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.003	0.997	0.000
W07.29 Fall involving chair; School, other institution and public administrative area; During unspecified activity	0.002	0.997	0.000
Y59.3 Immunoglobulin	0.002	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.997	0.003
W09 Fall involving playground equipment	0.002	0.997	0.000
Q21.0 Ventricular septal defect	0.000	0.997	0.003
V80-V89 Other land transport accidents	0.002	0.997	0.000
D52.9 Folate deficiency anaemia, unspecified	0.000	0.997	0.003
W09.0 Home	0.002	0.997	0.000
W20-W49 Exposure to inanimate mechanical forces	0.003	0.997	0.000
A40.1 Septicaemia due to streptococcus, group B	0.000	0.997	0.002
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
V40-V49 Car occupant injured in transport accident	0.002	0.997	0.000
V01-V09 Pedestrian injured in transport accident	0.002	0.997	0.000
A39.9 Meningococcal infection, unspecified	0.000	0.998	0.002
A39.8 Other meningococcal infections	0.000	0.998	0.002
A39.5 Meningococcal heart disease	0.000	0.998	0.002
A39.3 Chronic meningococcaemia	0.000	0.998	0.002
A39.2 Acute meningococcaemia	0.000	0.998	0.002
A39.1 Waterhouse-Friderichsen syndrome	0.000	0.998	0.002
A40.9 Streptococcal septicaemia, unspecified	0.000	0.998	0.002
X09 Exposure to unspecified smoke, fire and flames	0.002	0.998	0.000
V28.5 Passenger injured in traffic accident	0.002	0.998	0.000
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified	0.002	0.998	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.002	0.998	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.002	0.998	0.000
V28.9 Unspecified motorcycle rider injured in traffic accident	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.002	0.998	0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
W18 Other fall on same level	0.002	0.998	0.000
V70-V79 Bus occupant injured in transport accident	0.002	0.998	0.000
M24.8 Other specific joint derangements, not elsewhere classified	0.002	0.998	0.000
X09.0 Home	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
A40.2 Septicaemia due to streptococcus, group D	0.000	0.998	0.002
L27.1 Localised skin eruption due to drugs and medicaments	0.002	0.998	0.000
Y10-Y34 Event of undetermined intent	0.002	0.998	0.000
M24.07 Loose body in joint (Ankle and foot)	0.002	0.998	0.000
A39.4 Meningococcaemia, unspecified	0.000	0.998	0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.002	0.998	0.000
M24.83 Other specific joint derangements, not elsewhere classified (Forearm)	0.002	0.998	0.000
D26.9 Uterus, unspecified	0.000	0.998	0.002
V43 Car occupant injured in collision with car, pick-up truck or van	0.002	0.998	0.000
W01 Fall on same level from slipping, tripping and stumbling	0.002	0.998	0.000
X45 Accidental poisoning by and exposure to alcohol	0.002	0.998	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.002	0.998	0.000
Y35-Y36 Legal intervention and operations of war	0.002	0.998	0.000
X85-X99 Assault	0.002	0.998	0.000
X30-X39 Exposure to forces of nature	0.002	0.998	0.000
W65-W74 Accidental drowning and submersion	0.002	0.998	0.000
V90-V94 Water transport accidents	0.002	0.998	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.002	0.998	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.002	0.998	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
X43 Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
V95-V97 Air and space transport accidents	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.000	0.998	0.002
G54.0 Brachial plexus disorders	0.002	0.998	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.002	0.998	0.000
V24 Motorcycle rider injured in collision with heavy transport vehicle or bus	0.002	0.998	0.000
W94 Exposure to high and low air pressure and changes in air pressure	0.002	0.998	0.000
A39.0 Meningococcal meningitis	0.000	0.998	0.002
V01 Pedestrian injured in collision with pedal cycle	0.002	0.998	0.000
V22 Motorcycle rider injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
D35.0 Adrenal gland	0.000	0.998	0.002
V43.9 Unspecified car occupant injured in traffic accident	0.002	0.998	0.000
G94 Other disorders of brain in diseases classified elsewhere	0.002	0.998	0.000
V98 Other specified transport accidents	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y60.4 During endoscopic examination	0.002	0.998	0.000
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.002	0.998	0.000
A40.8 Other streptococcal septicaemia	0.000	0.998	0.002
G54.4 Lumbosacral root disorders, not elsewhere classified	0.002	0.998	0.000
G94.2 Hydrocephalus in other diseases classified elsewhere	0.002	0.998	0.000
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.002	0.998	0.000
X51.9 Unspecified place	0.002	0.998	0.000
X51.7 Farm	0.002	0.998	0.000
X51.6 Industrial and construction area	0.002	0.998	0.000
X51.5 Trade and service area	0.002	0.998	0.000
X51.4 Street and highway	0.002	0.998	0.000
X51.3 Sports and athletics area	0.002	0.998	0.000
X51.2 School, other institution and public administrative area	0.002	0.998	0.000
X51.1 Residential institution	0.002	0.998	0.000
X51.0 Home	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
D26 Other benign neoplasms of uterus	0.000	0.998	0.002
M24.84 Other specific joint derangements, not elsewhere classified (Hand)	0.002	0.998	0.000
X78.0 Home	0.002	0.998	0.000
V29 Motorcycle rider injured in other and unspecified transport accidents	0.002	0.998	0.000
W14 Fall from tree	0.002	0.998	0.000
W13 Fall from, out of or through building or structure	0.002	0.998	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
X59 Exposure to unspecified factor	0.002	0.998	0.000
W50-W64 Exposure to animate mechanical forces	0.002	0.998	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.002	0.998	0.000
W87 Exposure to unspecified electric current	0.002	0.998	0.000
X57 Unspecified privation	0.002	0.998	0.000
X54 Lack of water	0.002	0.998	0.000
X53 Lack of food	0.002	0.998	0.000
X52 Prolonged stay in weightless environment	0.002	0.998	0.000
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.000	0.998	0.002
V89.9 Person injured in unspecified vehicle accident	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
W40 Explosion of other materials	0.002	0.998	0.000
A40.0 Septicaemia due to streptococcus, group A	0.000	0.998	0.002
A48.4 Brazilian purpuric fever	0.000	0.998	0.002
A48.3 Toxic shock syndrome	0.000	0.998	0.002
A48.2 Nonpneumonic Legionnaires' disease [Pontiac fever]	0.000	0.998	0.002
A48.0 Gas gangrene	0.000	0.998	0.002
S22.3 Fracture of rib	0.000	0.998	0.002
V01.1 Traffic accident	0.002	0.998	0.000
X59.4 Street and highway	0.002	0.998	0.000
W16 Diving or jumping into water causing injury other than drowning or submersion	0.002	0.998	0.000
W12 Fall on and from scaffolding	0.002	0.998	0.000
W04 Fall while being carried or supported by other persons	0.002	0.998	0.000
C82.2 Large cell, follicular	0.000	0.998	0.002
X45.0 Home	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
V26 Motorcycle rider injured in collision with other nonmotor vehicle	0.002	0.998	0.000
V25 Motorcycle rider injured in collision with railway train or railway vehicle	0.002	0.998	0.000
V21 Motorcycle rider injured in collision with pedal cycle	0.002	0.998	0.000
V20 Motorcycle rider injured in collision with pedestrian or animal	0.002	0.998	0.000
W03 Other fall on same level due to collision with, or pushing by, another person	0.002	0.998	0.000
W29 Contact with other powered hand tools and household machinery	0.002	0.998	0.000
W78 Inhalation of gastric contents	0.002	0.998	0.000
M24.26 Disorder of ligament (Lower leg)	0.002	0.998	0.000
G93.4 Encephalopathy, unspecified	0.002	0.998	0.000
N85.8 Other specified noninflammatory disorders of uterus	0.002	0.998	0.000
S09.8 Other specified injuries of head	0.002	0.998	0.000
M24.2 Disorder of ligament	0.002	0.998	0.000
V28.4 Driver injured in traffic accident	0.002	0.998	0.000
V28.0 Driver injured in nontraffic accident	0.002	0.998	0.000
V28.3 Person injured while boarding or alighting	0.002	0.998	0.000
V28.1 Passenger injured in nontraffic accident	0.002	0.998	0.000
W18.5 Trade and service area	0.002	0.998	0.000
X43.0 Home	0.002	0.998	0.000
W83 Other specified threats to breathing	0.002	0.998	0.000
W81 Confined to or trapped in a low-oxygen environment	0.002	0.998	0.000
W77 Threat to breathing due to cave-in, falling earth and other substances	0.002	0.998	0.000
W76 Other accidental hanging and strangulation	0.002	0.998	0.000
W75 Accidental suffocation and strangulation in bed	0.002	0.998	0.000
X08 Exposure to other specified smoke, fire and flames	0.002	0.998	0.000
X06 Exposure to ignition or melting of other clothing and apparel	0.002	0.998	0.000
X05 Exposure to ignition or melting of nightwear	0.002	0.998	0.000
X04 Exposure to ignition of highly flammable material	0.002	0.998	0.000
X03 Exposure to controlled fire, not in building or structure	0.002	0.998	0.000
X02 Exposure to controlled fire in building or structure	0.002	0.998	0.000
X01 Exposure to uncontrolled fire, not in building or structure	0.002	0.998	0.000
C45.0 Mesothelioma of pleura	0.002	0.998	0.000
W22.8 Other specified place	0.002	0.998	0.000
W22.6 Industrial and construction area	0.002	0.998	0.000
W22.4 Street and highway	0.002	0.998	0.000
W22.0 Home	0.002	0.998	0.000
W22.7 Farm	0.002	0.998	0.000
W22.5 Trade and service area	0.002	0.998	0.000
W22.1 Residential institution	0.002	0.998	0.000
W79.9 Unspecified place	0.002	0.998	0.000
W79.0 Home	0.002	0.998	0.000
W79.8 Other specified place	0.002	0.998	0.000
W79.7 Farm	0.002	0.998	0.000
W79.6 Industrial and construction area	0.002	0.998	0.000
W79.5 Trade and service area	0.002	0.998	0.000
W79.4 Street and highway	0.002	0.998	0.000
W79.3 Sports and athletics area	0.002	0.998	0.000
W79.1 Residential institution	0.002	0.998	0.000
W94.8 Other specified place	0.002	0.998	0.000
W11 Fall on and from ladder	0.002	0.998	0.000
W99 Exposure to other and unspecified man-made environmental factors	0.002	0.998	0.000
W93 Exposure to excessive cold of man-made origin	0.002	0.998	0.000
W92 Exposure to excessive heat of man-made origin	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations